Knowles Julius

CIK 00018083651 companyLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001808365

Recent Transactions

50 trades

Disposition to Issuer
Keros Therapeutics, Inc.$KROS
Common Stock
2025-11-21$17.75/sh−191,527→ 150,047 total
Disposition to Issuer
Keros Therapeutics, Inc.$KROS
Common Stock
2025-11-21$17.75/sh−130,494→ 102,233 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-06-04+5,250→ 6,441 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-05-30+10,000→ 10,000 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2023-06-06+10,000→ 10,000 total
Award
Keros Therapeutics, Inc.$KROS
Stock Options (right to buy)
2022-06-01+8,293→ 8,293 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$57.23/sh−419→ 343,597 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$58.20/sh−886→ 233,162 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$59.00/sh−667→ 341,574 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$58.20/sh−1,356→ 342,241 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$59.00/sh−435→ 232,727 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-05$57.23/sh−271→ 234,048 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$58.86/sh−3,367→ 344,016 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$57.99/sh−2,704→ 236,514 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$54.95/sh−794→ 355,365 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$56.10/sh−2,124→ 353,241 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$58.86/sh−2,195→ 234,319 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$57.99/sh−4,151→ 347,383 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$56.95/sh−1,113→ 239,218 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$56.95/sh−1,707→ 351,534 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$56.10/sh−1,383→ 240,331 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-04$54.95/sh−524→ 241,714 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$58.96/sh−5,236→ 356,408 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$56.82/sh−3,678→ 366,738 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$57.83/sh−5,094→ 361,644 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$56.82/sh−2,406→ 249,130 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$59.40/sh−249→ 356,159 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$57.83/sh−3,318→ 245,812 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$59.40/sh−162→ 242,238 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2022-01-03$58.96/sh−3,412→ 242,400 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$53.86/sh−8,747→ 370,554 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$51.99/sh−79→ 385,673 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$53.17/sh−6,372→ 379,301 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$52.00/sh−52→ 261,486 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$53.86/sh−5,705→ 251,626 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$53.17/sh−4,155→ 257,331 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$54.67/sh−90→ 251,536 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-02$54.67/sh−138→ 370,416 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$55.71/sh−1,649→ 262,559 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$54.67/sh−5,168→ 389,846 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$56.27/sh−1,566→ 385,752 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$55.71/sh−2,528→ 387,318 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$56.27/sh−1,021→ 261,538 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$53.48/sh−4,243→ 395,014 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$54.67/sh−3,372→ 264,208 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-12-01$53.48/sh−2,766→ 267,580 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-11-03$42.45/sh−3,597→ 399,257 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-11-03$42.45/sh−2,346→ 270,346 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2021-11-03$41.65/sh−6,067→ 402,854 total

Companies

Keros Therapeutics, Inc.
Director
$KROS

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 1050 WALTHAM STREET, SUITE 302

LEXINGTON, MA, 02421

View on SEC.gov